Literature DB >> 2143169

Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement.

J Laurence1, A Saunders, E Early, J E Salmon.   

Abstract

Antibodies that augment human immunodeficiency virus (HIV) infectivity of monocytes through Fc receptor (FcR) type III for IgG have been found in the blood of sero-positive patients and immunized chimpanzees. This study investigated the effect of acute and chronic HIV infection, as well as protein kinase C activators capable of up-regulating latent HIV, on the expression of these receptors. In addition, the frequency of this antibody-dependent enhancement (ADE) phenomenon was estimated using purified IgG from HIV-1 seropositive individuals at various clinical stages of infection. The existence of an FcR-dependent pathway for ADE of HIV-1 infection in peripheral blood monocytes and promonocytic U937 cells was confirmed in sera from a small subset of patients, and the phenomenon extended to FcR types I and II. The level of ADE activity was minimal, however, and no relationship between the presence or magnitude of the ADE phenomenon and clinical stage was uncovered. Finally, perturbations which activate a latent HIV infection were shown to concomitantly up-regulate FcR on infected and uninfected cells. This suggests a positive feedback loop linking up-regulation of latent infection, enhanced expression of low affinity HIV receptors such as FcR, and viral spread.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143169      PMCID: PMC1384163     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors.

Authors:  T Jouault; F Chapuis; R Olivier; C Parravicini; E Bahraoui; J C Gluckman
Journal:  AIDS       Date:  1989-03       Impact factor: 4.177

2.  The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

Authors:  J Homsy; M Meyer; M Tateno; S Clarkson; J A Levy
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

3.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Authors:  J M Harouse; C Kunsch; H T Hartle; M A Laughlin; J A Hoxie; B Wigdahl; F Gonzalez-Scarano
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.

Authors:  M Tateno; F Gonzalez-Scarano; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Surface markers of monocyte function and activation in AIDS.

Authors:  B L Davidson; R L Kline; J Rowland; T C Quinn
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

6.  Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.

Authors:  W E Robinson; D C Montefiori; W M Mitchell; A M Prince; H J Alter; G R Dreesman; J W Eichberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.

Authors:  J Laurence; S M Friedman; E K Chartash; M K Crow; D N Posnett
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

Authors:  A M Prince; B Horowitz; L Baker; R W Shulman; H Ralph; J Valinsky; A Cundell; B Brotman; W Boehle; F Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription.

Authors:  J Laurence; M B Sellers; S K Sikder
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

10.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Authors:  A Takeda; C U Tuazon; F A Ennis
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

View more
  10 in total

Review 1.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

Review 2.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

3.  Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.

Authors:  Lautaro G Perez; Matthew R Costa; Christopher A Todd; Barton F Haynes; David C Montefiori
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

Review 4.  Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Authors:  Jop Jans; Marloes Vissers; Jacco G M Heldens; Marien I de Jonge; Ofer Levy; Gerben Ferwerda
Journal:  Rev Med Virol       Date:  2013-11-14       Impact factor: 6.989

5.  Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies.

Authors:  Vincent Holl; Maryse Peressin; Christiane Moog
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

6.  Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.

Authors:  R Crombie; R L Silverstein; C MacLow; S F Pearce; R L Nachman; J Laurence
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

Review 7.  Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

Authors:  Casey K Hua; Margaret E Ackerman
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

8.  Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2.

Authors:  Deyong Song; Wenbo Wang; Chuangchuang Dong; Zhenfei Ning; Xiu Liu; Chuan Liu; Guangying Du; Chunjie Sha; Kailin Wang; Jun Lu; Baiping Sun; Yanyan Zhao; Qiaoping Wang; Hongguang Xu; Ying Li; Zhenduo Shen; Jie Jiao; Ruiying Wang; Jingwei Tian; Wanhui Liu; Lan Wang; Yong-Qiang Deng; Changlin Dou
Journal:  Commun Biol       Date:  2021-04-23

9.  High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Authors:  Klaus Hirschbühl; Tina Schaller; Sebastian Dintner; Claudia Wylezich; Bruno Märkl; Rainer Claus; Eva Sipos; Lukas Rentschler; Andrea Maccagno; Bianca Grosser; Elisabeth Kling; Michael Neidig; Thomas Kröncke; Oliver Spring; Georg Braun; Hans Bösmüller; Maximilian Seidl; Irene Esposito; Jessica Pablik; Julia Hilsenbeck; Peter Boor; Martin Beer
Journal:  Mod Pathol       Date:  2022-04-01       Impact factor: 8.209

Review 10.  Which Antibody Functions are Important for an HIV Vaccine?

Authors:  Bin Su; Christiane Moog
Journal:  Front Immunol       Date:  2014-06-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.